GlassScriptPhysician profile
Sandra Haider
NPI 1992369060
$2,996.97
in general payments reported to CMS, 2019-2025
14 companies · $406 in 2025
The $406 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $2,178 · 2023: $224 · 2024: $189 · 2025: $406.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $819.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $818.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pinnacle, INC | $1,210.43 | 2022 | |
| Paragon 28, INC. | $671.73 | 2022 | |
| Treace Medical Concepts, INC. | $266.11 | 2025 | |
| Aroa Biosurgery Incorporated | $233.22 | 2022-2023 | |
| Nevro Corp. | $162.86 | 2022 | |
| Stryker Corporation | $143.59 | 2023-2025 | Prostep, Prostep Mica, Prophecy |
| Curonix LLC | $64.39 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Inari Medical, INC. | $58.86 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Medtronic, INC. | $44.75 | 2023-2025 | Intellis Adaptivestim, Inceptiv |
| Paratek Pharmaceuticals, INC. | $36.19 | 2024 | Nuzyra |
| Smith+Nephew, INC. | $32.07 | 2024 | Q-Fix, Bone Anchors With Arthroscopic Delivery System, Minitac |
| Averitas Pharma INC. | $28.79 | 2024 | Qutenza |
| Organogenesis INC. | $26.58 | 2025 | Cygnus Dual |
| Integra Lifesciences Corporation | $17.40 | 2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandra Haider listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.